Organization (Academic)
Hebrew University of Jerusalem
ClinicalTrials.gov lists Hebrew University of Jerusalem as lead sponsor of 31 trials. It has 1 active development program.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials started per year with this organization as sponsor or collaborator, 1990 onward. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.
2026 is partial: 2 registered with a 2026 start date. The dashed outline is the pace from the 2 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 3.4 trial starts a year over the five years to September, under the 5 a year the method needs.
Logo Hebrew University, via Wikimedia Commons, Public domain. Shown to identify the organization; it may be a registered trademark.
This page covers Hebrew University of Jerusalem: 31 lead-sponsored trials and 1 legal-entity registration.
Disease areas (54)
Shown in this order: most trials first.
| Disease area | Trials |
|---|---|
| Anxiety Disorders | 8 |
| Autism Spectrum Disorder | 5 |
| Attention Deficit Disorder with Hyperactivity | 3 |
| Inflammation | 3 |
| Pain | 3 |
Showing 5 of 54 disease areas.
Trials by start year as sponsor or collaborator (20)
Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Show the table of trials by start year as sponsor or collaborator
| Year | Trials started |
|---|---|
| 2026 (partial year) | 2 |
| 2025 | 3 |
| 2024 | 4 |
| 2023 | 2 |
| 2022 | 5 |
| 2021 | 9 |
| 2020 | 3 |
| 2019 | 5 |
| 2018 | 8 |
| 2017 | 8 |
Showing 10 of 20 years.
Prediction, not a registry value: median of 30 months from start to primary completion across 6 trials still running at the 2026-10-09 snapshot; 3 of 6 predicted trials reach the 36-month horizon; registered median of 18 months across 17 trials with a primary completion typed Actual. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
Active development programs (1)
| Drug | Disease area | Max phase | Trials |
|---|---|---|---|
| tDCS | Attention Deficit Disorder with Hyperactivity | Not reported | 1 |
Sponsor delivery record (1)
Enrollment hit target: the share of this sponsor's lead-sponsored trials whose actual enrollment reached the planned enrollment. On time: the share whose actual primary completion date was no later than the planned date. Each share counts only trials where we observed an estimated figure before the actual one, and n is that number of trials. Below 5 trials the count is shown as a fraction, not a percentage.
| Enrollment | Timeline |
|---|---|
| 44% hit target (n=9) | 30% on time (n=10) |
Journals published in (118)
Shown in this order: most published in first.
| Journal | Publications |
|---|---|
| Behaviour research and therapy | 5 |
| Journal of consulting and clinical psychology | 5 |
| NeuroImage | 4 |
| Proceedings of the National Academy of Sciences of the United States of America | 3 |
| Schizophrenia bulletin | 3 |
Showing 5 of 118 journals.
US granted patents (1)
Patents are not classified by disease area in the source, so this is the organization's overall portfolio, not a split by disease.
| US patents granted | Granted in the last 5 years | Most recent grant |
|---|---|---|
| 4 | 2 | 2023-12-05 |
Financing and grant events (7)
Shown in this order: most recent first.
| Date | Round type | Amount (USD) | Source |
|---|---|---|---|
| 2024-02-20 | NIH grant | 553,631 | Reporter |
| 2023-02-13 | NIH grant | 569,372 | Reporter |
| 2022-06-03 | NIH grant | 116,041 | Reporter |
| 2022-03-16 | NIH grant | 600,638 | Reporter |
| 2021-07-13 | NIH grant | 180,841 | Reporter |
Showing 5 of 7 events.
Organization relationships (12)
Shown in this order: most evidence first.
| Related organization | Relationship | Evidence |
|---|---|---|
| Hadassah Medical Organization | Co sponsors trial with | 3 |
| Shaare Zedek Medical Center | Co sponsors trial with | 1 |
| Tel Aviv University | Co sponsors trial with | 1 |
| Meir Medical Center | Co sponsors trial with | 1 |
| Technische Universität Dresden | Co sponsors trial with | 1 |
Showing 5 of 12 relationships.
Latest dated events (83)
Shown in this order: newest first.
| Date | Event | Source |
|---|---|---|
| 2026-08-12 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-01 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2025-12 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2025-11-16 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2025-03-30 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
Showing 5 of 83 events.
Biomarker capability evidence (19)
Shown in this order: tier desc, then gene symbol.
| Gene | Role | Evidence |
|---|---|---|
| H1-9P | Trial sponsor | Named in trial inclusion criteria |
| SERPINF2 | Trial sponsor | Named in trial inclusion criteria |
| SP2 | Trial collaborator | Named in trial inclusion criteria |
| SPIN1 | Trial sponsor | Named in trial inclusion criteria |
| SPIN1 | Trial sponsor | Named in trial inclusion criteria |
Showing 5 of 19 evidence rows.
Biomarkers this organization publishes on (279)
Shown in this order: most publications first.
Showing 5 of 279 biomarkers.
On Scientist.com
Hebrew University of Jerusalem is listed as a research supplier in the Scientist.com network.
Not on this page
Checked, with nothing recorded for this organization: companies grouped under this page, related companies not grouped here, approved assets, sec-reported annual financials, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, and clia clinical laboratory certificates.
Work with Hebrew University of Jerusalem on Scientist.com
For prices, more details, or to contact Hebrew University of Jerusalem, visit Scientist.com.
Sign in to Scientist.com to open this supplier in your organization's marketplace.